134 related articles for article (PubMed ID: 29590262)
41. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
42. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
Kwon MJ; Roh KH; Park H; Woo HY
J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
[TBL] [Abstract][Full Text] [Related]
44. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
45. PCR-RFLP-detected human papilloma virus infection in a group of senegalese women attending an STD clinic and identification of a new HPV-68 subtype.
Astori G; Beltrame A; Pipan C; Raphenon G; Botta GA
Intervirology; 1999; 42(4):221-7. PubMed ID: 10567840
[TBL] [Abstract][Full Text] [Related]
46. Distribution of human papillomavirus genotypes in women with cervical alterations from north Argentina.
Deluca GD; Marin HM; Blanco NS; Basiletti JA; González JV; Merino AL; Picconi MA
Indian J Med Microbiol; 2013; 31(2):138-41. PubMed ID: 23867669
[TBL] [Abstract][Full Text] [Related]
47. Analytical evaluation of the automated genotyping system (GenPlex) compared to a traditional real-time PCR assay for the detection of high-risk human papillomaviruses.
Zhang L; Ju Y; Hu H; Ma C; Yu Y; Huang Y; Gong L; Zhao W; Liu Y; Liu Y; Bian L
J Med Virol; 2024 Mar; 96(3):e29496. PubMed ID: 38402627
[TBL] [Abstract][Full Text] [Related]
48. Head-to-head comparison of genotyping of human papillomavirus by real-time multiplex PCR assay using type-specific primers and SPF10-PCR-based line probe assay.
Yin J; Peng S; Zhang C; Li X; Hu F; Chen W; Qiao Y
J Med Virol; 2023 Feb; 95(2):e28579. PubMed ID: 36786174
[TBL] [Abstract][Full Text] [Related]
49. Analysis of HPV genotype-specific concordance between EUROArray HPV and HPV 3.5 LCD-Array Kit in cervical samples of 163 patients.
Bräutigam K; Ehret C; Schillinger V; Baum S; Klar M; Köster F; Rody A; Panning M
Arch Gynecol Obstet; 2020 Mar; 301(3):745-751. PubMed ID: 31875249
[TBL] [Abstract][Full Text] [Related]
50. Type-specific detection of 30 oncogenic human papillomaviruses by genotyping both E6 and L1 genes.
Peng J; Gao L; Guo J; Wang T; Wang L; Yao Q; Zhu H; Jin Q
J Clin Microbiol; 2013 Feb; 51(2):402-8. PubMed ID: 23152557
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus detection using PCR and ATR-FTIR for cervical cancer screening.
Rymsza T; Ribeiro EA; de Carvalho LFDCES; Bhattacharjee T; de Azevedo Canevari R
Spectrochim Acta A Mol Biomol Spectrosc; 2018 May; 196():238-246. PubMed ID: 29454252
[TBL] [Abstract][Full Text] [Related]
52. [Human papilloma virus genotyping assay using restriction fragment mass polymorphism analysis, and its comparison with sequencing and hybrid capture assays].
Lee EH; Chung HJ; Oh HB; Chi HS; Jee MS; Park SN; Hong SP; Yoo W; Kim SO
Korean J Lab Med; 2007 Feb; 27(1):62-8. PubMed ID: 18094553
[TBL] [Abstract][Full Text] [Related]
53. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types.
Lai HC; Sun CA; Yu MH; Chen HJ; Liu HS; Chu TY
Int J Cancer; 1999 Dec; 84(6):553-7. PubMed ID: 10567897
[TBL] [Abstract][Full Text] [Related]
54. Pitfalls of commercially available HPV tests in HPV68a detection.
Jaworek H; Kubanova K; Koudelakova V; Slavkovsky R; Drabek J; Hajduch M
PLoS One; 2019; 14(8):e0220373. PubMed ID: 31381580
[TBL] [Abstract][Full Text] [Related]
55. Hybrid capture II and PapilloCheck® tests for detection of anal high-risk human papillomavirus.
Maia LB; Marinho LC; Bocca AL; Cavalcante Neto FF; Velasco LF; Costa PG; Carneiro FP; Oliveira PG
Rev Soc Bras Med Trop; 2014; 47(2):227-30. PubMed ID: 24861299
[TBL] [Abstract][Full Text] [Related]
56. Head-to-head comparison of genotyping of human papillomavirus by GP5+/6+-PCR-based reverse dot blot hybridization assay and SPF10-PCR-based line probe assay.
Yin J; Peng S; Li X; Zhang C; Hu F; Chen W; Qiao Y
J Med Virol; 2023 Feb; 95(2):e28435. PubMed ID: 36571268
[TBL] [Abstract][Full Text] [Related]
57. [Application of multiplex PCR capillary electrophoresis and analysis of distribution characteristics of HPV infection subtypes].
Gao Y; Jiang Y; Tie YQ; Yu D; Zhao MC; Tan H; Tang ZP; Zhang WC; Feng ZS
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Mar; 57(3):393-399. PubMed ID: 36922173
[No Abstract] [Full Text] [Related]
58. Detection of human papillomaviruses by polymerase chain reaction and ligation reaction on universal microarray.
Ritari J; Hultman J; Fingerroos R; Tarkkanen J; Pullat J; Paulin L; Kivi N; Auvinen P; Auvinen E
PLoS One; 2012; 7(3):e34211. PubMed ID: 22457826
[TBL] [Abstract][Full Text] [Related]
59. Detection and Typing of Human Papilloma Viruses by Nested Multiplex Polymerase Chain Reaction Assay in Cervical Cancer.
Jalal Kiani S; Shatizadeh Malekshahi S; Yousefi Ghalejoogh Z; Ghavvami N; Shafiei Jandaghi NZ; Shahsiah R; Jahanzad I; Yavarian J
Jundishapur J Microbiol; 2015 Dec; 8(12):e26441. PubMed ID: 26865940
[TBL] [Abstract][Full Text] [Related]
60. The cytology and DNA detection by the PapilloCheck(®) test in the diagnosis of human papillomavirus infection.
Vieira L; Almeida A
Eur J Microbiol Immunol (Bp); 2013 Mar; 3(1):61-7. PubMed ID: 24265920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
